Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 8652399 | HLA-A*02 | transfusion-related acute lung injury | NA | NA | NA | unclassified | |
| transfusion-related acute lung injury due to hla-a2-specific antibodies in recipient and nb1-specific antibodies in donor blood. | |||||||
| 15303536 | HLA-DR (HLA-DR) | transfusion-related acute lung injury | NA | NA | NA | unclassified | |
| immunological testing of blood from the 2 donors and the patient revealed the presence of anti-hla dr-52 antibodies in the plasma of a donor and the presence of the corresponding antigen in the patient, confirming the diagnosis of fresh frozen plasma transfusion-related acute lung injury. | |||||||
| 18282262 | HLA (HLA) | transfusion-related acute lung injury | NA | NA | NA | negation | |
| human leucocyte antigen (hla) antibodies have been implicated in transfusion-related acute lung injury, but the probability that the transfusion of a blood component containing hla antibodies will cause a reaction is not known. | |||||||
| 19413730 | HLA (HLA) | transfusion-related acute lung injury | NA | NA | NA | unclassified | |
| current transfusion-related acute lung injury reduction strategies include avoiding transfusion of plasma products collected from female donors or female donors that have been pregnant to reduce transfusion of plasma-containing hla antibodies. | |||||||
| 20158696 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | transfusion-related acute lung injury | NA | NA | NA | unclassified | |
| and sthe activation of neutrophils by human leukocyte antigen (hla) class i alloantibody is thought to be involved in transfusion-related acute lung injury. | |||||||
| 21173129 | HLA (HLA) | transfusion-related acute lung injury | NA | NA | NA | unclassified | |
| a retrospective review of recipients of packed rbcs and platelets processed from these 33 hla-immunized male donors were conducted to identify transfusion-related acute lung injury and cognate antigens. | |||||||
| 21492179 | HLA (HLA) | transfusion-related acute lung injury | NA | NA | NA | unclassified | |
| transfusion-related acute lung injury (ali) has occurred in patients whose underlying condition led to an inflamed endothelium and who were transfused with products that contained either hla or hna antibodies or biologic modifiers such as lipids or antigens from stored cells. | |||||||
| 23305156 | HLA (HLA) | transfusion-related acute lung injury | NA | NA | NA | unclassified | |
| identifying antibodies to hla (anti-hla) by solid-phase assays is used to screen blood donors to mitigate transfusion-related acute lung injury risk. | |||||||
| 23305735 | HLA-E (HLA-E) | transfusion-related acute lung injury | NA | NA | NA | unclassified | |
| at the same time, anti-hla-e mab, which reacts only to hla-i hcs, is unlikely to produce transfusion-related acute lung injury, in contrast to antibodies reacting to intact-hla. | |||||||
| 25380867 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | transfusion-related acute lung injury | NA | NA | NA | unclassified | |
| post-transfusion reactions of anti-human leukocyte antigen antibodies (anti-hla) are responsible for transfusion-related acute lung injury, but cases of graft rejection after blood product infusions were recently also proven. | |||||||
Copyright 2024